Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption

(2014) Maryam Moosavi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Agmatine Induces Nrf2 and Protects Against Corticosterone Effects in Hippocampal Neuronal Cell Line

(2014) Andiara E. Freitas et al.   MOLECULAR NEUROBIOLOGY

Role of Oxidative Stress in Parkinson's Disease

(2013) Onyou Hwang   Experimental Neurobiology

Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

(2012) Filipe C. Matheus et al.   BEHAVIOURAL BRAIN RESEARCH

Agmatine promotes the migration of murine brain endothelial cells via multiple signaling pathways

(2012) Hyun-Joo Jung et al.   LIFE SCIENCES

Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation

(2012) Maryam Moosavi et al.   NEUROPHARMACOLOGY

Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP+, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells

(2012) Ju-Xian Song et al.   NEUROSCIENCE LETTERS

ERK1/2 MAP kinases: Structure, function, and regulation

(2012) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson’s disease

(2011) Salvatore Condello et al.   AMINO ACIDS

Akt as a Victim, Villain and Potential Hero in Parkinson’s Disease Pathophysiology and Treatment

(2011) Lloyd A. Greene et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine

(2010) Hiroo Yamanaka et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Agmatine effects on mitochondrial membrane potential andNF-κB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells

(2010) Salvatore Condello et al.   JOURNAL OF NEUROCHEMISTRY

The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis

(2009) Mary Ann Arndt et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Agmatine prevents the Ca2+-dependent induction of permeability transition in rat brain mitochondria

(2009) V. Battaglia et al.   AMINO ACIDS

Can cellular models revolutionize drug discovery in Parkinson's disease?

(2009) Birgitt Schüle et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

ERK and cell death: ERK1/2 in neuronal death

(2009) Srinivasa Subramaniam et al.   FEBS Journal

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

3-Isobutylmethylxanthine Inhibits Hepatic Urea Synthesis

(2008) Itzhak Nissim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Parkin Protects Dopaminergic Neurons against Microtubule-depolymerizing Toxins by Attenuating Microtubule-associated Protein Kinase Activation

(2008) Yong Ren et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research

(2008) Yuen-Ting Cheung et al.   NEUROTOXICOLOGY